NZ220611A - 30 residue influenza virus peptide, vaccines and antibodies - Google Patents

30 residue influenza virus peptide, vaccines and antibodies

Info

Publication number
NZ220611A
NZ220611A NZ22061183A NZ22061183A NZ220611A NZ 220611 A NZ220611 A NZ 220611A NZ 22061183 A NZ22061183 A NZ 22061183A NZ 22061183 A NZ22061183 A NZ 22061183A NZ 220611 A NZ220611 A NZ 220611A
Authority
NZ
New Zealand
Prior art keywords
vaccines
antibodies
residue
influenza virus
virus peptide
Prior art date
Application number
NZ22061183A
Inventor
N Green
S Alexander
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Priority claimed from NZ205341A external-priority patent/NZ205341A/en
Publication of NZ220611A publication Critical patent/NZ220611A/en

Links

NZ22061183A 1982-08-23 1983-08-22 30 residue influenza virus peptide, vaccines and antibodies NZ220611A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23
NZ205341A NZ205341A (en) 1982-08-23 1983-08-22 37 residue influenza virus peptide and vaccines

Publications (1)

Publication Number Publication Date
NZ220611A true NZ220611A (en) 1988-07-28

Family

ID=26650577

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ22061183A NZ220611A (en) 1982-08-23 1983-08-22 30 residue influenza virus peptide, vaccines and antibodies

Country Status (1)

Country Link
NZ (1) NZ220611A (en)

Similar Documents

Publication Publication Date Title
NZ205341A (en) 37 residue influenza virus peptide and vaccines
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
IL61904A (en) Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
ZA829386B (en) Modified vaccinia virus and methods for making and using the same
EP0083286A3 (en) Modified vaccinia virus and methods for making and using the same
AU1255383A (en) Foot and mouth disease viral antigenic peptides
IL80895A0 (en) Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
AU8746582A (en) Hepatitis b virus e type antigen
AU5978586A (en) Vaccines and diagnostics derived from bovine diarrhea virus
DE3361141D1 (en) Infectious bronchitis vaccines
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
NZ220611A (en) 30 residue influenza virus peptide, vaccines and antibodies
ZA903142B (en) Canine corona virus vaccine
EP0244427A4 (en) Recombinant virus.
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
HUT43110A (en) New antigene-active proteines and peptides and infective bronchitis virus /ibv/ vaccines
GB8412158D0 (en) Recombinant dna derived antigens
DE3263582D1 (en) Peptide, process for preparation thereof and use thereof
GB8406901D0 (en) Virus vaccine
GB8306609D0 (en) Virus vaccine
GB8608991D0 (en) Virus vaccine
IE880458L (en) Virus antigen
GB8712042D0 (en) Virus & vaccine